Patient reported outcomes (PRO) are gaining in importance in therapy areas that have been dominated historically by biomarkers or event-based endpoints.
Change in requirements for PRO evidence and a rising bar for its quality are being driven by regulators but payers are also increasingly demanding high-quality patient-relevant outcomes. To meet new requirements and to differentiate its products, Pharma must integrate the patient experience strategy into its development programs.
Join this webinar to learn more about:
- The evolving PRO landscape – current challenges and opportunities and their development over time;
- How PROs are assessed by payers and regulators;
- How you can be successful in this challenging environment and develop a strategy that meets these requirements; and
- Case studies in oncology and rare diseases – what works and doesn’t work.